Stockscreener 앱 받기
0.275
3.98%
-0.0114
시간 외 거래:
.28
0.005
+1.82%
전일 마감가:
$0.2864
열려 있는:
$0.29
하루 거래량:
1.27M
Relative Volume:
0.22
시가총액:
$11.50M
수익:
-
순이익/손실:
$-27.04M
주가수익비율:
-0.1393
EPS:
-1.9743
순현금흐름:
$-17.53M
1주 성능:
-8.33%
1개월 성능:
-38.48%
6개월 성능:
-88.04%
1년 성능:
-93.56%
1일 변동 폭
$0.25
$0.29
1주일 범위
$0.25
$0.3049
52주 변동 폭
$0.25
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
명칭
Medicus Pharma Ltd
전화
610-540-7515
주소
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX vs LLY, JNJ, ABBV, AZN, MRK
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
0.275 | 11.98M | 0 | -27.04M | -17.53M | -1.9743 |
LLY
Lilly Eli Co
|
988.87 | 863.14B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
225.55 | 539.70B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
206.11 | 368.19B | 62.82B | 3.62B | 17.82B | 2.0331 |
AZN
Astrazeneca Plc
|
181.24 | 284.52B | 60.48B | 10.40B | 8.05B | 3.3297 |
MRK
Merck Co Inc
|
113.15 | 279.37B | 65.59B | 8.93B | 12.36B | 3.5532 |
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Medicus Pharma Meets Lawmakers to Advance SkinJect Program - MyChesCo
Medicus reports Phase 2 basal cell carcinoma trial results By Investing.com - Investing.com India
MDCX Forecast, Price Target & Analyst Ratings | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
Medicus Pharma on Bloomberg World - Public Opinion
Medicus Pharma 2025 Executive Compensation, Board Governance, and Equity Incentive Plan Overview - Minichart
Medicus Pharma (Nasdaq: MDCX) details board structure and leadership pay - Stock Titan
Exclusive: Medicus Pharma refines trial design to cut costs, accelerate development for enlarged prostate patients - MSN
MDCXW Price History for Medicus Pharma Ltd WT Stock - Barchart
MDCX Technical Analysis | Trend, Signals & Chart Patterns | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
Medicus Pharma lobbies Congress on SkinJect regulatory pathway for rare Gorlin syndrome - Yahoo! Finance Canada
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill - The Manila Times
Medicus Pharma to acquire Antev for $75M in share exchange transaction - MSN
Medicus Pharma prices $7 million share offering - MSN
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global - ACCESS Newswire
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ - marketscreener.com
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines - TipRanks
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Wisconsin Farmer
Medicus Pharma (NASDAQ: MDCX) ups ATM to $50M; Nasdaq bid‑price notice - Stock Titan
Medicus Pharma receives Nasdaq notice for minimum bid price non-compliance - Investing.com UK
Medicus Pharma Expands ATM Equity Program for Funding - TipRanks
Medicus Pharma Upsizes ATM Program to $50 Million With Maxim Group and Yorkville Securities - TradingView
Nasdaq warns Medicus Pharma (NASDAQ: MDCX) on $1 bid price rule - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Medicus Pharma advances Skinject in rare disease – ICYMI - Proactive financial news
Medicus Pharma to acquire Antev - MSN
Medicus Pharma Ltd may offer and sell common shares up to $50 million aggregate through agents - marketscreener.com
Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents - TradingView
MDCX (NASDAQ: MDCX) increases equity ATM to $50,000,000 with Maxim, Yorkville - Stock Titan
ICYMI: Medicus Pharma Seeks FDA Orphan Drug Designation for SkinJect in Gorlin Syndrome - Dermatology Times
3 Stocks To BUY NOW In March 2026 (wLdea9HGKw) - Fathom Journal
Medicus Pharma (MDCX) Stock: Important Info (Institutional Selling) 2026-04-22Popular Trader Picks - Cổng thông tin điện tử tỉnh Tây Ninh
Is Medicus Pharma (MDCX) stock forming a breakout | Q4 2025: Earnings UnderperformNetwork Effect - Xã Thanh Hà
Medicus Pharma Submits Orphan Drug Application for SkinJect - MyChesCo
Analysts’ Top Healthcare Picks: Surrozen (SRZN), Establishment Labs Holdings (ESTA) - The Globe and Mail
Exclusive: Penny stock Medicus Pharma findings support potential in women's health pipeline - MSN
Medicus Pharma (MDCX) asks shareholders to approve up to 50-for-1 reverse split - Stock Titan
Medicus Pharma to Present Phase 1 Data on Teverelix at AACE 2026 - MyChesCo
Medicus Pharma Is Maintained at Buy by D. Boral Capital - Moomoo
Medicus Pharma files Orphan Drug application for SkinJect in rare skin Cancer indication - Proactive financial news
MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM ESTShow #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Viv - ChartMill
Medicus Pharma Ltd (MDCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.57%
자본화:
|
볼륨(24시간):